Press Releases about Alzamend Neuro, Inc. - Common Stock![]() ![]() ![]()
Alzamend Neuro Has Regained Compliance with Nasdaq's Minimum Bid Price Requirement
September 22, 2022
From Alzamend Neuro, Inc.
Via Business Wire
![]() From Alzamend Neuro, Inc.
Via Business Wire
![]() ![]()
Alzamend Neuro Announces Reverse Stock Split
October 30, 2023
From Alzamend Neuro, Inc.
Via Business Wire
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]()
Alzamend Neuro to Present at Sequire Biotechnology Conference
January 26, 2023
From Alzamend Neuro, Inc.
Via Business Wire
![]() ![]() From Alzamend Neuro, Inc.
Via Business Wire
![]() ![]() ![]() ![]() ![]() ![]() From Alzamend Neuro, Inc.
Via Business Wire
![]() ![]() ![]()
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|